Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | 68 299 | déclaré | 01 déc. 2023 | tx 55+565 980−139 588 |
| ACUCELA INC. | 66 587 | déclaré | 17 juil. 2017 | tx 40+317 098−103 421 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 01 déc. 2023 | SALE | Apellis Pharmaceuticals, Inc. | 10 000 | 60.00 USD | |
| 01 déc. 2023 | EXERCISE | Apellis Pharmaceuticals, Inc. | 10 000 | 13.85 USD | |
| 01 déc. 2023 | EXERCISE | Apellis Pharmaceuticals, Inc. | 10 000 | 0.00 USD | deriv |
| 06 sept. 2023 | SALE | Apellis Pharmaceuticals, Inc. | 1 756 | 43.01 USD | |
| 21 févr. 2023 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 715 | 58.50 USD | |
| 21 févr. 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 9 886 | 0.00 USD | |
| 21 févr. 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 14 023 | 0.00 USD | deriv |
| 10 févr. 2023 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 678 | 51.21 USD | |
| 27 janv. 2023 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 542 | 52.77 USD | |
| 20 janv. 2023 | TAX_WITHHOLDING | Apellis Pharmaceuticals, Inc. | 2 015 | 52.05 USD | |
| 12 janv. 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 22 580 | 0.00 USD | |
| 12 janv. 2023 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 35 472 | 52.66 USD | deriv |
| 27 mai 2022 | SALE | Apellis Pharmaceuticals, Inc. | 10 000 | 43.00 USD | |
| 21 avr. 2022 | OTHER | Apellis Pharmaceuticals, Inc. | 1 875 | 0.00 USD | |
| 21 avr. 2022 | OTHER | Apellis Pharmaceuticals, Inc. | 11 250 | 0.00 USD | deriv |
| 05 avr. 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 609 | 13.85 USD | |
| 05 avr. 2022 | SALE | Apellis Pharmaceuticals, Inc. | 609 | 60.09 USD | |
| 05 avr. 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 609 | 0.00 USD | deriv |
| 04 avr. 2022 | SALE | Apellis Pharmaceuticals, Inc. | 1 249 | 57.81 USD | |
| 04 avr. 2022 | SALE | Apellis Pharmaceuticals, Inc. | 1 437 | 56.86 USD | |
| 04 avr. 2022 | SALE | Apellis Pharmaceuticals, Inc. | 818 | 55.84 USD | |
| 04 avr. 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 3 504 | 13.85 USD | |
| 04 avr. 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 3 504 | 0.00 USD | deriv |
| 01 avr. 2022 | SALE | Apellis Pharmaceuticals, Inc. | 11 496 | 55.05 USD | |
| 01 avr. 2022 | EXERCISE | Apellis Pharmaceuticals, Inc. | 11 496 | 13.85 USD |